Currently out of the existing stock ratings of Joori Park, 3 are a BUY (100%).

Joori Park

Work Performance Price Targets & Ratings Chart

Analyst Joori Park, currently employed at LEERINK,

Joori Park has documented 5 price targets and ratings displayed on 1 stocks.

Most recent stock forecast was given on LRMR, Larimar Therapeutics at 29-Sep-2025.

Wall Street Analyst Joori Park

Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
LRMR Larimar Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Oct-2024

$9

$5.86 (186.62%)

$11

5 days ago
(17-Nov-2026)

Buy Since 20-Mar-2015

$13

$9.86 (314.01%)

$132

2 months 8 days ago
(14-Sep-2026)

1/5 (20%)

$9.22 (243.92%)

1022

Buy Since 10-Feb-2021

$18

$14.86 (473.25%)

$18

4 months 15 days ago
(07-Jul-2026)

0/16 (0%)

$14.59 (427.86%)

Buy Since 03-Sep-2024

$5

$1.86 (59.24%)

$7

4 months 23 days ago
(30-Jun-2026)

0/5 (0%)

$1.95 (63.93%)

Buy Since 13-Feb-2024

$14

$10.86 (345.86%)

8 months 28 days ago
(25-Feb-2026)

3/7 (42.86%)

$8.05 (135.29%)

88

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Joori Park?

On 2024
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?